Effect of long-chain noncoding RNA LINC01204 on malignant biological behavior of bladder cancer by up-regulating GPC5 gene expression
10.3760/cma.j.issn.1008-1372.2019.05.015
- VernacularTitle:长链非编码RNA LINC01204上调GPC5基因表达对膀胱癌恶性生物学行为的影响
- Author:
Jiandong ZHANG
1
;
Jianwen LI
;
Zhiping ZHAO
;
Yangang ZHANG
Author Information
1. 山西大医院泌尿外科
- Keywords:
RNA,long noncoding;
Glypicans;
Urinary bladder neoplasms;
Cell proliferation;
Cell migration assays;
In vitro
- From:
Journal of Chinese Physician
2019;21(5):700-704
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the upregulation of long-chain non-coding RNA LINC01204 on the expression of glypican-5 (GPC5) gene in bladder cancer cells and its effect on the proliferation,migration and invasion of bladder cancer cells.Methods Quantitative real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of LINC01204 in 12 cases of bladder cancer tissues and paracancerous tissues,bladder cancer cell lines (BIU-87,T24,J82,5637) and normal bladder epithelial cell SV-HUC-1.The bladder cancer cells with the lowest level of LINC01204 were infected with lentivirus particles carrying LINC01204 (experimental group) or infected with negative control lentivirus particles (control group),and the expression of LINC01204 and GPC5 were detected by qRT-PCR in both groups of cells.Western blot was used to detect the expression of GPC5 protein in the two groups of cells.Cell counting kit-8 (CCK-8) and Transwell chamber assays were used to determine cell proliferation,migration and invasion.Results The expression of LINC01204 in bladder cancer tissues (0.773 ±0.063) was significantly higher than that in adjacent tissues (3.665 ± 0.330),with statistically significant difference (t =8.612,P ＜ 0.001).The expression of LINC01204 in bladder cancer cell lines BIU-87 (0.320 ± 0.034),T24 (0.515 ±0.056),J82 (0.644 ±0.039),and 5637 (0.147 ±0.018) were lower than that of normal bladder epithelial cells SV-HUC-1 (1.009 ± 0.077),with statistically significant difference (t =8.160,P＜0.001;t=5.179,P=0.002;t=4.221,P=0.006;t=10.890,P＜0.001).The expression of LINC01204 in 5637 cells was the lowest.The expression of LINC01204 and GPC5 mRNA in experimental group were significantly higher than that in the control group,with statistically significant difference [(11.000±1.028) vs (1.019 ±0.119),t =9.651,P＜0.001;(4.476 ±0.347) vs (1.046 ± 0.163),t =8.962,P ＜ 0.001],with statistically significant difference.Western blot showed that the expression of GPC5 protein was up-regulated.Compared with the control group,the proliferation ability of 5637 cells infected with LINC01204 in experimental group began to decrease significantly from the third day (0.686 ±0.044 vs 0.536 ±0.026,t =2.943,P =0.026).The number of migration cells in experimental group (118.300 ± 16.260) was significantly lower than that in the control group (208.200 ±22.930),with statistically significant difference (t =3.198,P =0.019).The number of cell invasion in experimental group (50.390 ±5.368) was significantly lower than that in the control group (97.480 ± 15.350),with statistically significant difference (t =2.896,P =0.028).Conclusions LINC01204 can upregulate the expression of GPC5 gene and inhibit the proliferation,migration and invasion of bladder cancer cells.Targeted therapy for LINC01204 is expected to become a new gene therapy method for bladder cancer.
